Related Experiment Video
Updated: Nov 1, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter
Hyo-Ju Son1, Tark Kim2, Eunjung Lee3
1Division of Infectious Diseases, Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Soonchunhyang University College of Medicine, Seoul, Republic of Korea; Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Objectives:
Superimposed multi-drug resistant organisms (MDROs) co-infection can be associated with worse outcomes in patients with severe coronavirus disease 2019 (COVID-19), even if these patients were managed with strict airborne and contact precautions. Identifying risk factors for isolation of MDROs is critical to COVID-19 treatment.
Methods:
All eligible adult patients with confirmed COVID-19 pneumonia from 10 hospitals in the Republic of Korea between February 2020 and May 2020 were retrospectively enrolled. Using this cohort, epidemiology and risk factors for isolation of MDROs were evaluated.
Results:
Of 152 patients, 47 with microbial culture results were included. Twenty isolates of MDROs from 13 (28%) patients were cultured. Stenotrophomonas maltophilia (5 isolates) was the most common MDRO, followed by methicillin-resistant staphylococcus aureus (4 isolates). MDROs were mostly isolated from sputum samples (80%, 16/20). The median time from hospitalization to MDRO isolation was 28 days (interquartile range, 18-38 days). In-hospital mortality was higher in patients with MDRO isolation (62% vs 15%; P = .001). Use of systemic corticosteroids after diagnosis of COVID-19 (adjusted odds ratio [aOR]: 15.07; 95% confidence interval [CI]: 2.34-97.01; P = .004) and long-term care facility (LTCF) stay before diagnosis of COVID-19 (aOR: 6.09; 95% CI: 1.02-36.49; P = .048) were associated with MDRO isolation.
Conclusions:
MDROs were isolated from 28% of COVID-19 pneumonia patients with culture data and 8.6% of the entire cohort. Previous LTCF stay and adjunctive corticosteroid use were risk factors for the isolation of MDROs. Strict infection prevention strategies may be needed in these COVID-19 patients with risk factors.
Insights
Multi-drug resistant organism (MDRO) co-infections in severe COVID-19 patients are linked to higher mortality. Previous long-term care facility stays and corticosteroid use are key risk factors for MDRO isolation.
Area of Science:
- Infectious Diseases
- Critical Care Medicine
- Microbiology
Background:
- Severe coronavirus disease 2019 (COVID-19) patients face risks from co-infections with multi-drug resistant organisms (MDROs).
- Identifying MDRO risk factors is crucial for improving outcomes in COVID-19 patients, even with stringent precautions.
Purpose of the Study:
- To evaluate the epidemiology of MDRO isolation in hospitalized COVID-19 pneumonia patients.
- To identify risk factors associated with MDRO isolation in this patient population.
Main Methods:
- Retrospective analysis of 152 adult COVID-19 pneumonia patients from 10 hospitals in South Korea (February-May 2020).
- Focus on 47 patients with available microbial culture results to assess MDRO prevalence and characteristics.
- Statistical analysis to identify risk factors for MDRO isolation.
Main Results:
- MDROs were isolated from 28% of patients with culture data (13/47), with Stenotrophomonas maltophilia and MRSA being most common.
- MDROs were primarily isolated from sputum samples, with a median isolation time of 28 days post-hospitalization.
- In-hospital mortality was significantly higher in patients with MDRO isolation (62% vs. 15%, P=.001).
Conclusions:
- MDRO isolation occurred in 28% of cultured COVID-19 patients, significantly increasing mortality risk.
- Pre-existing long-term care facility (LTCF) residency and the use of systemic corticosteroids post-COVID-19 diagnosis were identified as significant risk factors for MDRO isolation.
- Enhanced infection prevention strategies are recommended for COVID-19 patients with identified risk factors.
More Related Videos
08:58Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
07:13Swabbing the Urban Environment - A Pipeline for Sampling and Detection of SARS-CoV-2 From Environmental Reservoirs
Published on: April 9, 2021
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Single Nucleotide Polymorphisms-SNPs
Transmission-based Precautions II: Airborne and Protective Environment
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
Pneumonia II: Pathophysiology
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Development of Antibiotic Resistance